SomPharmaceuticals is Therapeutic Devices in Switzerland that focus on market opportunities business. Founded in 2012. They cover business area such as provider, rare disease, novel anti-tumour somatostatin analogue, SSA, peptide medicine, diagnostic, patient, unmet medical need, major market opportunity, growth hormone, pituitary brain tumour, acromegaly, malignant neuroendocrine hormone, intestinal and pancreatic tumour, NETs, lanreotide.
2012
( 12 years old in 2024 )
Market Opportunities
-
Route de la Corniche 4
1066 Epalinges
Switzerland
Private
providerrare diseasenovel anti-tumour somatostatin analogueSSApeptide medicinediagnosticpatientunmet medical needmajor market opportunitygrowth hormonepituitary brain tumouracromegalymalignant neuroendocrine hormoneintestinal and pancreatic tumourNETslanreotide
* We use standard office opening hours in near SomPharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
SomPharmaceuticals is Therapeutic Devices business from Switzerland that founded in 2012 (12 years old in 2024), SomPharmaceuticals business is focusing on Market Opportunities.
SomPharmaceuticals headquarter office and corporate office address is located in Route de la Corniche 4 1066 Epalinges Switzerland.
SomPharmaceuticals was founded in Switzerland.
In 2024, SomPharmaceuticals is currently focus on market opportunities sector.
Above is snippet of Google Trends for "market opportunities" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with SomPharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
